Cargando…

Prenatal exposure to antifungal medication may change anogenital distance in male offspring: a preliminary study

BACKGROUND: Vaginal candidiasis is frequent among pregnant women and it is treated with anti-fungal medication (conazoles). Conazoles have anti-androgenic properties and prenatal exposure in rodents is associated with a shorter (less masculine) anogenital distance (AGD) in male offspring. To our kno...

Descripción completa

Detalles Bibliográficos
Autores principales: Mogensen, Djamilla Madelung, Pihl, Maria Bergkvist, Skakkebæk, Niels E., Andersen, Helle Raun, Juul, Anders, Kyhl, Henriette Boye, Swan, Shanna, Kristensen, David Møbjerg, Andersen, Marianne Skovager, Lind, Dorte Vesterholm, Jensen, Tina Kold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480178/
https://www.ncbi.nlm.nih.gov/pubmed/28637461
http://dx.doi.org/10.1186/s12940-017-0263-z
_version_ 1783245254143508480
author Mogensen, Djamilla Madelung
Pihl, Maria Bergkvist
Skakkebæk, Niels E.
Andersen, Helle Raun
Juul, Anders
Kyhl, Henriette Boye
Swan, Shanna
Kristensen, David Møbjerg
Andersen, Marianne Skovager
Lind, Dorte Vesterholm
Jensen, Tina Kold
author_facet Mogensen, Djamilla Madelung
Pihl, Maria Bergkvist
Skakkebæk, Niels E.
Andersen, Helle Raun
Juul, Anders
Kyhl, Henriette Boye
Swan, Shanna
Kristensen, David Møbjerg
Andersen, Marianne Skovager
Lind, Dorte Vesterholm
Jensen, Tina Kold
author_sort Mogensen, Djamilla Madelung
collection PubMed
description BACKGROUND: Vaginal candidiasis is frequent among pregnant women and it is treated with anti-fungal medication (conazoles). Conazoles have anti-androgenic properties and prenatal exposure in rodents is associated with a shorter (less masculine) anogenital distance (AGD) in male offspring. To our knowledge this has never been studied in humans. METHOD: In the Odense Child Cohort pregnant women residing in Odense municipality, Denmark, were recruited at gestational age 8–16 weeks between 2010 and 2012. Of the eligible 2421 mother-child pairs, 812 mother-son pairs were included. Questionnaire data on medicine use were collected in first and third trimester and physical examination at age 3 month was performed. Ano-scrotal distance; measured from the centre of anus to the posterior base of scrotum (AGDas). Ano-cephalad distance; measured from the centre of anus to the cephalad insertion of the penis (AGDap) and penile width; measured at the base of the penis. RESULTS: Eighty seven women had used antifungal medicine during pregnancy. Maternal use of oral fluconazole (n = 4) was associated with a 6.4 mm shorter AGDas (95% CI: -11.9;-0.9) in the male offspring. Use of antifungal vaginal tablets (n = 21), was associated with a non-significantly shorter AGDas (−1.9 mm; 95% CI: -4.3; 0.5) whereas exposure to vaginal cream (n = 23) was not associated to AGDas. Use of antifungal medicine in the window of genital development between 8 and 14 weeks of gestation was associated with a larger reduction in AGDas than exposure outside this window. Antifungal medicine intake was not associated with AGDap and penil width. CONCLUSION: Our preliminary findings prompted us to hypothesize that maternal use of conazole antifungal medication during pregnancy may affect the masculinization of male offspring. If confirmed, pregnant women should be advised to use antifungal medicine with caution. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12940-017-0263-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5480178
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54801782017-06-23 Prenatal exposure to antifungal medication may change anogenital distance in male offspring: a preliminary study Mogensen, Djamilla Madelung Pihl, Maria Bergkvist Skakkebæk, Niels E. Andersen, Helle Raun Juul, Anders Kyhl, Henriette Boye Swan, Shanna Kristensen, David Møbjerg Andersen, Marianne Skovager Lind, Dorte Vesterholm Jensen, Tina Kold Environ Health Research BACKGROUND: Vaginal candidiasis is frequent among pregnant women and it is treated with anti-fungal medication (conazoles). Conazoles have anti-androgenic properties and prenatal exposure in rodents is associated with a shorter (less masculine) anogenital distance (AGD) in male offspring. To our knowledge this has never been studied in humans. METHOD: In the Odense Child Cohort pregnant women residing in Odense municipality, Denmark, were recruited at gestational age 8–16 weeks between 2010 and 2012. Of the eligible 2421 mother-child pairs, 812 mother-son pairs were included. Questionnaire data on medicine use were collected in first and third trimester and physical examination at age 3 month was performed. Ano-scrotal distance; measured from the centre of anus to the posterior base of scrotum (AGDas). Ano-cephalad distance; measured from the centre of anus to the cephalad insertion of the penis (AGDap) and penile width; measured at the base of the penis. RESULTS: Eighty seven women had used antifungal medicine during pregnancy. Maternal use of oral fluconazole (n = 4) was associated with a 6.4 mm shorter AGDas (95% CI: -11.9;-0.9) in the male offspring. Use of antifungal vaginal tablets (n = 21), was associated with a non-significantly shorter AGDas (−1.9 mm; 95% CI: -4.3; 0.5) whereas exposure to vaginal cream (n = 23) was not associated to AGDas. Use of antifungal medicine in the window of genital development between 8 and 14 weeks of gestation was associated with a larger reduction in AGDas than exposure outside this window. Antifungal medicine intake was not associated with AGDap and penil width. CONCLUSION: Our preliminary findings prompted us to hypothesize that maternal use of conazole antifungal medication during pregnancy may affect the masculinization of male offspring. If confirmed, pregnant women should be advised to use antifungal medicine with caution. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12940-017-0263-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-21 /pmc/articles/PMC5480178/ /pubmed/28637461 http://dx.doi.org/10.1186/s12940-017-0263-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mogensen, Djamilla Madelung
Pihl, Maria Bergkvist
Skakkebæk, Niels E.
Andersen, Helle Raun
Juul, Anders
Kyhl, Henriette Boye
Swan, Shanna
Kristensen, David Møbjerg
Andersen, Marianne Skovager
Lind, Dorte Vesterholm
Jensen, Tina Kold
Prenatal exposure to antifungal medication may change anogenital distance in male offspring: a preliminary study
title Prenatal exposure to antifungal medication may change anogenital distance in male offspring: a preliminary study
title_full Prenatal exposure to antifungal medication may change anogenital distance in male offspring: a preliminary study
title_fullStr Prenatal exposure to antifungal medication may change anogenital distance in male offspring: a preliminary study
title_full_unstemmed Prenatal exposure to antifungal medication may change anogenital distance in male offspring: a preliminary study
title_short Prenatal exposure to antifungal medication may change anogenital distance in male offspring: a preliminary study
title_sort prenatal exposure to antifungal medication may change anogenital distance in male offspring: a preliminary study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480178/
https://www.ncbi.nlm.nih.gov/pubmed/28637461
http://dx.doi.org/10.1186/s12940-017-0263-z
work_keys_str_mv AT mogensendjamillamadelung prenatalexposuretoantifungalmedicationmaychangeanogenitaldistanceinmaleoffspringapreliminarystudy
AT pihlmariabergkvist prenatalexposuretoantifungalmedicationmaychangeanogenitaldistanceinmaleoffspringapreliminarystudy
AT skakkebæknielse prenatalexposuretoantifungalmedicationmaychangeanogenitaldistanceinmaleoffspringapreliminarystudy
AT andersenhelleraun prenatalexposuretoantifungalmedicationmaychangeanogenitaldistanceinmaleoffspringapreliminarystudy
AT juulanders prenatalexposuretoantifungalmedicationmaychangeanogenitaldistanceinmaleoffspringapreliminarystudy
AT kyhlhenrietteboye prenatalexposuretoantifungalmedicationmaychangeanogenitaldistanceinmaleoffspringapreliminarystudy
AT swanshanna prenatalexposuretoantifungalmedicationmaychangeanogenitaldistanceinmaleoffspringapreliminarystudy
AT kristensendavidmøbjerg prenatalexposuretoantifungalmedicationmaychangeanogenitaldistanceinmaleoffspringapreliminarystudy
AT andersenmarianneskovager prenatalexposuretoantifungalmedicationmaychangeanogenitaldistanceinmaleoffspringapreliminarystudy
AT linddortevesterholm prenatalexposuretoantifungalmedicationmaychangeanogenitaldistanceinmaleoffspringapreliminarystudy
AT jensentinakold prenatalexposuretoantifungalmedicationmaychangeanogenitaldistanceinmaleoffspringapreliminarystudy